Fig. 7From: Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus studyDosing Modification due to Drug Interactions. Statements with a consensus for are bolded; statements with consensus against are shown with a grey backgroundBack to article page